Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9987986 | Alzheimer's & Dementia: Translational Research & Clinical Interventions | 2018 | 14 Pages |
Abstract
Together, the funding and financing entities involved in supporting AD drug development comprise a complex, interactive, dynamic financial ecosystem. Funding source interaction is largely unstructured and available funding is insufficient to meet all demands for new therapies. Novel approaches to funding such as mega-funds have been proposed and more integration of component parts would assist in accelerating drug development.
Keywords
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Jeffrey Cummings, Carl Reiber, Parvesh Kumar,